Published in Lab Business Week, November 19th, 2006
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Alnylam Pharmaceuticals.
Report 1: Alnylam Pharmaceuticals, Inc., (ALNY) announced that Vincent Miles, PhD, senior VP, Business Development, is planning to leave the company to pursue his interests in other areas.
He will remain with Alnylam on a full-time basis through the end of the year and will then work through a transition period as the company identifies a replacement. After almost thirty years of employment in the biotechnology...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week